Literature DB >> 9559793

Prophylaxis of acute osteomyelitis with absorbable ofloxacin-impregnated beads.

D P Nicolau1, L Nie, P R Tessier, H P Kourea, C H Nightingale.   

Abstract

We investigated the use of an ofloxacin-impregnated bioabsorbable composite for the prevention of acute Staphylococcus aureus osteomyelitis. New Zealand White rabbits were anesthetized, the femur was exposed, and a cortical hole was drilled. Animals were randomly given drug-free composites or ofloxacin-impregnated composites; the composites were placed at the site of injury, and the incision was closed. One hour later, all animals were intravenously inoculated with 5 x 10(4) CFU of S. aureus and observed for 28 days. Bone culture data revealed that S. aureus was isolated from 3 of 12 rabbits in the ofloxacin composite group and 9 of 11 animals in the control group (P = 0.02). Radiographic evaluation revealed that the drug-free group had a significantly (P = 0.01) greater degree of radiographic evidence of infection than the group given ofloxacin composites. Although a limited number of histologic samples were available, these data also paralleled the radiographic and culture data. This study demonstrates the effectiveness of the implantable ofloxacin bioabsorbable composites to prevent the development of acute osteomyelitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9559793      PMCID: PMC105552          DOI: 10.1128/AAC.42.4.840

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Hyperbaric oxygenation. Its effect on experimental staphylococcal osteomyelitis in rats.

Authors:  D L Hamblen
Journal:  J Bone Joint Surg Am       Date:  1968-09       Impact factor: 5.284

2.  Collagen with gentamicin for prophylaxis of postoperative infection. Staphylococcus aureus osteomyelitis studied in rabbits.

Authors:  P Riegels-Nielsen; F Espersen; L R Hölmich; N Frimodt-Møller
Journal:  Acta Orthop Scand       Date:  1995-02

3.  Deep infection following total hip arthroplasty.

Authors:  J P Nelson
Journal:  J Bone Joint Surg Am       Date:  1977-12       Impact factor: 5.284

4.  Acute hematogenous osteomyelitis: a model with trauma as an etiology.

Authors:  R T Morrissy; D W Haynes
Journal:  J Pediatr Orthop       Date:  1989 Jul-Aug       Impact factor: 2.324

5.  A bioabsorbable delivery system for antibiotic treatment of osteomyelitis. The use of lactic acid oligomer as a carrier.

Authors:  G Wei; Y Kotoura; M Oka; T Yamamuro; R Wada; S H Hyon; Y Ikada
Journal:  J Bone Joint Surg Br       Date:  1991-03

6.  The prevention of infection in open fractures. An experimental study of the effect of antibiotic therapy.

Authors:  P Worlock; R Slack; L Harvey; R Mawhinney
Journal:  J Bone Joint Surg Am       Date:  1988-10       Impact factor: 5.284

7.  Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa.

Authors:  M E Klepser; K B Patel; D P Nicolau; R Quintiliani; C H Nightingale
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

8.  Resection arthroplasty following infected total hip arthroplasty.

Authors:  W Petty; S Goldsmith
Journal:  J Bone Joint Surg Am       Date:  1980-09       Impact factor: 5.284

9.  In vitro elution of ofloxacin from a bioabsorbable polymer.

Authors:  L Nie; D P Nicolau; C H Nightingale; B D Browner; R Quintiliani
Journal:  Acta Orthop Scand       Date:  1995-08

10.  Biodegradation of and tissue reaction to 50:50 poly(DL-lactide-co-glycolide) microcapsules.

Authors:  G E Visscher; R L Robison; H V Maulding; J W Fong; J E Pearson; G J Argentieri
Journal:  J Biomed Mater Res       Date:  1985-03
View more
  3 in total

1.  The drug release study of ceftriaxone from porous hydroxyapatite scaffolds.

Authors:  Zeki N Al-Sokanee; Abedl Amer H Toabi; Mohammed J Al-Assadi; Erfan A S Alassadi
Journal:  AAPS PharmSciTech       Date:  2009-06-05       Impact factor: 3.246

Review 2.  Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds.

Authors:  Viviana Mouriño; Aldo R Boccaccini
Journal:  J R Soc Interface       Date:  2009-10-28       Impact factor: 4.118

Review 3.  Use of quinolones in osteomyelitis and infected orthopaedic prosthesis.

Authors:  D P Lew; F A Waldvogel
Journal:  Drugs       Date:  1999       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.